JEA BizDev Consulting, LLC®

Find your next opportunity.

HomeConnecting science. Creating value.PagesServicesExpertise across the BD value chainPagesAbout JohnExperience behind the partnershipsPagesOur approachFrom strategy to signed agreementPagesOpportunitiesExplore assets for partneringPagesTrack recordPartnerships and downloadable deal summariesPagesStart a conversationDiscuss an opportunity with JohnPagesMy cross-border dealsJEA reference library on Google DriveTransactionsCross-border deal libraryJEA reference library on Google DriveTransactionsDLL3 ADCOncology · IND Filing · DLL3AssetsHER2 Biparatopic ADCOncology · Phase 3 · HER2AssetsFRα Biparatopic ADCOncology · IND Filing · FRαAssetsCYP11B2 InhibitorCardiovascular · IND Filing · CYP11B2AssetsENPP1 InhibitorCardiovascular · IND Approved · ENPP1AssetsB7-H3 ADCOncology · Phase 1 · B7-H3AssetsATM InhibitorOncology · Phase 1 · ATMAssetsKAT6 InhibitorOncology · Phase 1 · KAT6A / KAT6BAssetsEGFR-ADCOncology · Phase 3 · EGFRAssetsNovaRock × Bionyra (2026)Exclusive license agreement for NBL-023, a novel anti–IL-25 monoclonal antibody, granting worldwide rights outside Greater China.TransactionsNovaRock × LigaChemBio (2026)Global out-licensing agreement for an ADC candidate targeting a novel oncology antigen.TransactionsCSPC × Radiance Biopharma (2025)$1,240 million strategic partnership for ROR1-ADC (SYS6005).TransactionsCSPC × Cipla (2025)$1,065 million strategic partnership for an Irinotecan Liposomal Injection product.TransactionsNovaRock × LigaChemBio (2025)Two global out-licensing agreements for novel antibodies.Transactions

OUR SERVICES

The right expertise. At every stage.

Strategic advice and hands-on execution for biotech and biopharma companies. A focused engagement or a partner for the entire partnering process.

01Strategy

Strategic guidance

Expert advice to navigate strategic initiatives and business development activities.

Define the opportunity, clarify portfolio priorities, and shape an actionable partnering strategy.

02Strategy

Deal benchmarking

Deal benchmarks and deal sheet summaries to inform your next negotiation.

Put transaction structures in context with relevant precedents and a clear view of headline versus contingent value.

03Partnering

Partner identification

Connect with the right collaborators in the industry.

Build a focused partner universe around scientific fit, development capability, territory, and strategic priorities.

04Partnering

Industry connections & outreach

An established international network, working for your success.

Position your opportunity, initiate conversations, and move interest toward a meaningful evaluation.

05Execution

Business development operations

Streamline your processes for optimal efficiency.

Bring structure to opportunity tracking, partner communications, and decision-making across the partnering process.

06Execution

Due diligence management

Lead and support thorough evaluation of potential partnerships.

Coordinate workstreams, surface key questions, and help teams work toward informed transaction decisions.

07Transactions

Deal structuring

Craft terms that support successful collaborations.

Align rights, responsibilities, upfront consideration, milestones, and royalties with the objectives of both parties.

08Transactions

Contract negotiation & closure

Secure favorable agreements and a smooth transition.

Support commercial negotiations and work alongside your legal and technical teams through agreement and handover.

09Execution

Full partnering process oversight

Comprehensive, end-to-end management of your partnership activities.

A single experienced advisor across strategy, search and evaluation, transaction negotiation, and alliance management.

THE NEXT CONVERSATION COULD CHANGE EVERYTHING

Great science deserves
the right partnership.

Let’s talk about where you want to go,
and how we can help you get there.

Start a conversation